124 related articles for article (PubMed ID: 7694053)
21. Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection.
Usher LR; Lawson RA; Geary I; Taylor CJ; Bingle CD; Taylor GW; Whyte MK
J Immunol; 2002 Feb; 168(4):1861-8. PubMed ID: 11823520
[TBL] [Abstract][Full Text] [Related]
22. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes.
Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B
Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966
[TBL] [Abstract][Full Text] [Related]
23. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
[TBL] [Abstract][Full Text] [Related]
24. Hemorrhage Attenuates Neutrophil Recruitment in Response to Secondary Respiratory Infection by Pseudomonas Aeruginosa.
Lee K; Cohen JT; Wilson ZS; Zhao R; Lomas-Neira J; Chung CS; Chen Y; Jamieson AM; Ayala A; Lefort CT
Shock; 2019 Nov; 52(5):506-512. PubMed ID: 30475329
[TBL] [Abstract][Full Text] [Related]
25. The effect of antipolymorphonuclear leucocyte serum on Pseudomonas aeruginosa infection in rabbits.
Bullen JJ; Wallis SN; Griffiths E
Immunology; 1976 May; 30(5):603-10. PubMed ID: 819359
[TBL] [Abstract][Full Text] [Related]
26. Bispecific antibody targets multiple Pseudomonas aeruginosa evasion mechanisms in the lung vasculature.
Thanabalasuriar A; Surewaard BG; Willson ME; Neupane AS; Stover CK; Warrener P; Wilson G; Keller AE; Sellman BR; DiGiandomenico A; Kubes P
J Clin Invest; 2017 Jun; 127(6):2249-2261. PubMed ID: 28463232
[TBL] [Abstract][Full Text] [Related]
27. Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway.
Fick RB; Sonoda F; Hornick DB
Semin Respir Infect; 1992 Sep; 7(3):168-78. PubMed ID: 1475541
[TBL] [Abstract][Full Text] [Related]
28. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
Pedersen SS
APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
[TBL] [Abstract][Full Text] [Related]
29. Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages.
Cabral DA; Loh BA; Speert DP
Pediatr Res; 1987 Oct; 22(4):429-31. PubMed ID: 2891100
[TBL] [Abstract][Full Text] [Related]
30. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
Pier GB
Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
[TBL] [Abstract][Full Text] [Related]
31. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis.
Kolpen M; Hansen CR; Bjarnsholt T; Moser C; Christensen LD; van Gennip M; Ciofu O; Mandsberg L; Kharazmi A; Döring G; Givskov M; Høiby N; Jensen PØ
Thorax; 2010 Jan; 65(1):57-62. PubMed ID: 19846469
[TBL] [Abstract][Full Text] [Related]
32. NKG2D is critical for NK cell activation in host defense against Pseudomonas aeruginosa respiratory infection.
Wesselkamper SC; Eppert BL; Motz GT; Lau GW; Hassett DJ; Borchers MT
J Immunol; 2008 Oct; 181(8):5481-9. PubMed ID: 18832705
[TBL] [Abstract][Full Text] [Related]
33. Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis.
Suarez-Cuartin G; Smith A; Abo-Leyah H; Rodrigo-Troyano A; Perea L; Vidal S; Plaza V; Fardon TC; Sibila O; Chalmers JD
Respir Med; 2017 Jul; 128():1-6. PubMed ID: 28610665
[TBL] [Abstract][Full Text] [Related]
34. Immunology of Pseudomonas aeruginosa infection in cystic fibrosis.
Høiby N; Pedersen SS; Jensen ET; Pressler T; Shand GH; Kharazmi A; Döring G
Acta Univ Carol Med (Praha); 1990; 36(1-4):16-21. PubMed ID: 2130683
[TBL] [Abstract][Full Text] [Related]
35. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
[TBL] [Abstract][Full Text] [Related]
36. The role of the microcolony mode of growth in the pathogenesis of Pseudomonas aeruginosa infections.
Costerton JW; Lam J; Lam K; Chan R
Rev Infect Dis; 1983; 5 Suppl 5():S867-73. PubMed ID: 6419312
[TBL] [Abstract][Full Text] [Related]
37. Pseudomonas aeruginosa infection in cystic fibrosis. Distribution of B and T lymphocytes in relation to the humoral immune response.
Hoiby N; Mathiesen L
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):559-66. PubMed ID: 4213329
[No Abstract] [Full Text] [Related]
38. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study.
Pressler T; Frederiksen B; Skov M; Garred P; Koch C; Høiby N
J Cyst Fibros; 2006 Jan; 5(1):9-15. PubMed ID: 16412706
[TBL] [Abstract][Full Text] [Related]
39.
Öz HH; Zhou B; Voss P; Carevic M; Schroth C; Frey N; Rieber N; Hector A; Hartl D
Front Cell Infect Microbiol; 2016; 6():167. PubMed ID: 27965936
[No Abstract] [Full Text] [Related]
40. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
Pier GB; Saunders JM; Ames P; Edwards MS; Auerbach H; Goldfarb J; Speert DP; Hurwitch S
N Engl J Med; 1987 Sep; 317(13):793-8. PubMed ID: 2957591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
